Longevity is where biological ambition meets human evidence.
The field is full of real science, weak claims, commercial pressure, and public desire. That combination makes judgment essential.
Vastkind covers longevity through one question: what is actually supported by evidence, and what is still a story people want to believe?
Start here
These pieces give the clearest entry point into Vastkind's longevity coverage.
- What Is Longevity Science? is the foundation guide for understanding aging biology, healthspan evidence, biomarkers, and where claims break.
- The Longevity Industry Has a Measurement Problem explains why the field cannot mature without better ways to measure progress.
- Biological Age Testing: What Epigenetic Clocks Can Tell You-and What They Can't shows why biomarkers are useful, but easy to overread.
- Rapamycin Still Needs Human Proof separates a serious biological hypothesis from a finished human longevity claim.
What changed recently
Longevity is moving from broad promises toward harder clinical reality.
- Partial Epigenetic Reprogramming Human Trial: Longevity's Reality Check explains why human trials matter more than rejuvenation language.
- The First Human Rejuvenation Trial: What ER-100 Really Changes looks at what a real trial can prove, and what it cannot.
- Senolytics in Humans: Why the First Real Clinical Reality Check Matters More Than the Hype shows why human data is the dividing line.
Essential reading
The useful longevity question is not whether aging biology is real. It is what has crossed from mechanism into human proof.
- NMN vs NR in 2026: What Human Trials Actually Show
- Partial Reprogramming OSK vs OSKM: Why Partial Is the Whole Trick
- David Sinclair's Information Theory of Aging: Powerful Idea, Uneven Proof
- AI + Quantum Longevity Forecast: The Kurzweil Narrative vs the Trial Timeline
- Longevity Will Not Break the Planet by Itself. Frailty, Emissions, and Inequality Might.
Evidence boundary
Longevity coverage needs more caution than ordinary technology coverage.
A demo, a mouse study, a biomarker movement, a founder claim, or a supplement mechanism is not the same as longer healthy human life.
Vastkind treats that difference as the center of the story.
Read next
If you want the biotechnology layer behind longevity, follow Biotech.
If you want weekly orientation instead of a feed, get The Vastkind Briefing.